Europe Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
유럽 뇌척수액(CSF) 관리 시장은 2022년에 5억 4,431만 달러로 평가되었고, 2030년에는 8억 1,712만 달러에 이를 것으로 예측되며, 예측기간 동안 복합 연간 성장률(CAGR) 5.2%로 성장할 것으로 예측됩니다.
CSF관리 분야의 연구개발이 유럽 뇌척수액(CSF) 관리 시장을 촉진
이 지역의 수액 관리 분야의 연구 개발은 의학 지식의 향상, 환자의 결과의 개선, 치료 방법의 강화에 임하고 있는 것이 특징입니다. 유럽 국가들은 건강 관리 연구 및 혁신에 적극적으로 투자하는 것으로 알려져 있으며, 수액 관리 분야에 크게 기여하고 있습니다. 예를 들어, 연구기관과 대학은 수두증과 같은 치료에서 매우 중요한 수액 션트 시스템 개선을 목적으로 하는 프로젝트에서 협력하고 있습니다. 이러한 공동 연구의 결과 합병증을 줄이고 환자의 삶의 질을 향상시키는 혁신적인 설계, 재료, 저침습 기술이 만들어지는 경우가 많습니다.
또한 유럽은 수액 관련 질환에 대한 임상시험의 최전선에 있습니다. 이러한 임상시험은 특발성 두개내 압항증(IIH) 및 정상 압수두증(NPH)과 같은 질병에 대한 새로운 진단 도구 및 치료법의 개발에 중점을 둡니다. 예를 들어, 현재 진행중인 NPH의 진단 기준과 치료법에 대한 연구는 환자의 표준 치료를 형성하는 것입니다. 또한, 바이오마커 연구는 뇌척수액 분석에 의한 진단 능력을 향상시키고 있습니다. 이러한 이니셔티브는 이 지역이 수액 관리의 발전에 주력하고 있음을 나타냅니다. 따라서 향후 몇 년동안 시장 성장을 뒷받침할 것으로 예상됩니다.
유럽 뇌척수액(CSF) 관리 시장 개요
유럽 뇌척수액(CSF) 관리 시장은 독일, 영국, 프랑스, 이탈리아, 스페인 및 기타 유럽으로 구분됩니다. 독일과 영국과 같은 국가들은 이 지역 시장에 가장 큰 기여자가 될 것으로 예상됩니다. 뇌척수액 감소증과 악성 중추 신경계 종양의 유병률의 상승이 유럽에서 동 시장의 성장을 가속하는 주요 요인입니다.
유럽 뇌척수액(CSF) 관리 시장 수익과 예측(-2030년)(US$Mn)
유럽 뇌척수액(CSF) 관리 시장의 세분화
유럽 뇌척수액(CSF) 관리 시장은 제품, 최종 사용자, 국가로 구분됩니다.
제품별로 유럽 뇌척수액(CSF) 관리 시장은 CSF 션트와 CSF 배수 시스템으로 이분됩니다. 2022년에는 CSF 션트 부문이 큰 시장 점유율을 차지했습니다.
최종 사용자별로 보면 유럽 뇌척수액(CSF) 관리 시장은 병원, 클리닉, 외래수술센터(ASC) 등으로 구분됩니다. 병원 부문은 2022년에 가장 큰 시장 점유율을 차지했습니다.
국가별로 유럽 뇌척수액(CSF) 관리 시장은 영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽으로 구분됩니다. 2022년 유럽 뇌척수액(CSF) 관리 시장 점유율은 독일이 독점.
Argi Group Health Services Ltd Sti, B. Braun SE, Delta Surgical Ltd, Integra LifeSciences Holdings Corp, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc, Sophisa SA, Spiegelberg GmbH &Co KG는 유럽 뇌척수액(CSF) 관리 시장에서 사업을 전개하는 대기업의 일부입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 유럽 뇌척수액(CSF) 관리 시장 상황
제5장 유럽 뇌척수액(CSF) 관리 시장-주요 산업역학
- 시장 성장 촉진요인
- 뇌척수액 누출 증례 증가
- 수액 관리 분야의 연구 개발
- 시장 성장 억제요인
- 시장 기회
- 신경질환 치료에 있어서의 수액 관리에 대한 주목의 고조
- 향후의 동향
- 영향 분석
제6장 뇌척수액(CSF) 관리 시장-유럽 시장 분석
- 유럽 뇌척수액(CSF) 관리 시장의 매출액(2022년-2030년)
제7장 유럽 뇌척수액(CSF) 관리 시장 - 수익과 예측(-2030년) : 제품별
- 시장수익 점유율(2022년, 2030년)
- 수액 션트
- 수액 배수 시스템
제8장 유럽 뇌척수액(CSF) 관리 시장 - 수익과 예측(-2030년) : 최종 사용자별
- 시장수익 점유율(2022년, 2030년)
- 병원
- 진료소
- 외래수술센터(ASC)
- 기타
제9장 유럽 뇌척수액(CSF) 관리 시장 : 국가별 분석
- 유럽 뇌척수액(CSF) 관리 시장 : 국가별
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
제10장 유럽 뇌척수액(CSF) 관리 시장 : 업계 정세
- 유럽 뇌척수액(CSF) 관리 시장에서의 성장 전략(2020년-2023년)
- 무기적 성장 전략
- 유기적 성장 전략
제11장 기업 프로파일
- Medtronic Plc
- Integra LifeSciences Holdings Corp
- B. Braun SE
- Argi Group Health Services Ltd Sti
- Sophysa SA
- Delta Surgical Ltd
- Moller Medical GmbH
- Natus Medical Inc
- Spiegelberg GmbH & Co KG
제12장 부록
BJH
The Europe cerebrospinal fluid management market was valued at US$ 544.31 million in 2022 and is expected to reach US$ 817.12 million by 2030; it is estimated to grow at a CAGR of 5.2% from 2022 to 2030.
R&D in the Field of CSF Management Fuels the Europe Cerebrospinal Fluid Management Market
R&D in the field of CSF management in the region is marked by a commitment to advancing medical knowledge, improving patient outcomes, and enhancing treatment modalities. European countries are renowned for their robust investments in healthcare research and innovation, making significant contributions to the field of CSF management. For example, research institutions and universities collaborate on projects aimed at improving CSF shunt systems, which are pivotal in the treatment of conditions like hydrocephalus. These collaborations often result in innovative designs, materials, and minimally invasive techniques that reduce complications and improve patient quality of life.
Furthermore, Europe is at the forefront of clinical trials related to CSF-related disorders. These trials focus on the development of novel diagnostic tools and treatments for conditions such as idiopathic intracranial hypertension (IIH) or normal pressure hydrocephalus (NPH). For instance, the ongoing research into the diagnostic criteria and treatment options for NPH is shaping the standard of care for patients. Additionally, biomarker research is advancing the ability to diagnose through cerebrospinal fluid analysis. These initiatives represent the region's focus on advancing CSF management. Thus, it is expected to bolster the growth of the market during the coming years.
Europe Cerebrospinal Fluid Management Market Overview
The Europe cerebrospinal fluid management market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of iNPH and malignant CNS tumors are the major factors driving the growth of this market in Europe.
Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Europe Cerebrospinal Fluid Management Market Segmentation
The Europe cerebrospinal fluid management market is segmented into product, end user and country.
Based on product, the Europe cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.
Based on end user, the Europe cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Europe cerebrospinal fluid management market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe cerebrospinal fluid management market share in 2022.
Argi Group Health Services Ltd Sti, B. Braun SE, Delta Surgical Ltd, Integra LifeSciences Holdings Corp, Medtronic Plc, Moller Medical GmbH, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Europe cerebrospinal fluid management market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Cerebrospinal Fluid Management Market Landscape
- 4.1 Overview
- 4.2 Europe PEST Analysis
5. Europe Cerebrospinal Fluid Management Market - Key Industry Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
- 5.1.2 R&D in the Field of CSF Management
- 5.2 Market Restraints
- 5.2.1 Risk of Failure and Malfunctioning
- 5.3 Market Opportunities
- 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
- 5.4 Future Trends
- 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
- 5.5 Impact Analysis:
6. Cerebrospinal Fluid Management Market - Europe Market Analysis
- 6.1 Europe Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
7. Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product
- 7.1 Overview
- 7.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
- 7.3 CSF Shunts
- 7.3.1 Overview
- 7.3.2 CSF Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Ventriculoperitoneal Shunts
- 7.3.3.1 Overview
- 7.3.3.2 Ventriculoperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Ventriculoatrial Shunts
- 7.3.4.1 Overview
- 7.3.4.2 Ventriculoatrial Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Ventriculopleural Shunts
- 7.3.5.1 Overview
- 7.3.5.2 Ventriculopleural Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Lumboperitoneal Shunts
- 7.3.6.1 Overview
- 7.3.6.2 Lumboperitoneal Shunts: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 CSF Drainage Systems
- 7.4.1 Overview
- 7.4.2 CSF Drainage Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 External Ventricular Drainage (EVD) Systems
- 7.4.3.1 Overview
- 7.4.3.2 External Ventricular Drainage (EVD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Lumbar Drainage (LD) Systems
- 7.4.4.1 Overview
- 7.4.4.2 Lumbar Drainage (LD) Systems: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User
- 8.1 Overview
- 8.2 Europe Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
- 8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Clinics
- 8.4.1 Overview
- 8.4.2 Clinics: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Ambulatory Surgical Centers
- 8.5.1 Overview
- 8.5.2 Ambulatory Surgical Centers: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Europe Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Cerebrospinal Fluid Management Market - Country Analysis
- 9.1 Overview
- 9.1.1.1 Europe Cerebrospinal Fluid Management Market, by Country
- 9.1.1.2 UK
- 9.1.1.2.1 Overview
- 9.1.1.2.2 UK: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.1.2.3 UK: Europe Cerebrospinal Fluid Management Market, by Product
- 9.1.1.2.3.1 UK: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
- 9.1.1.2.3.2 UK: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
- 9.1.1.2.4 UK: Europe Cerebrospinal Fluid Management Market, by End User
- 9.1.1.3 Germany
- 9.1.1.3.1 Overview
- 9.1.1.3.2 Germany: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.1.3.3 Germany: Europe Cerebrospinal Fluid Management Market, by Product
- 9.1.1.3.3.1 Germany: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
- 9.1.1.3.3.2 Germany: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
- 9.1.1.3.4 Germany: Europe Cerebrospinal Fluid Management Market, by End User
- 9.1.1.4 France
- 9.1.1.4.1 Overview
- 9.1.1.4.2 France: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.1.4.3 France: Europe Cerebrospinal Fluid Management Market, by Product
- 9.1.1.4.3.1 France: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
- 9.1.1.4.3.2 France: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
- 9.1.1.4.4 France: Europe Cerebrospinal Fluid Management Market, by End User
- 9.1.1.5 Italy
- 9.1.1.5.1 Overview
- 9.1.1.5.2 Italy: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.1.5.3 Italy: Europe Cerebrospinal Fluid Management Market, by Product
- 9.1.1.5.3.1 Italy: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
- 9.1.1.5.3.2 Italy: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
- 9.1.1.5.4 Italy: Europe Cerebrospinal Fluid Management Market, by End User
- 9.1.1.6 Spain
- 9.1.1.6.1 Overview
- 9.1.1.6.2 Spain: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.1.6.3 Spain: Europe Cerebrospinal Fluid Management Market, by Product
- 9.1.1.6.3.1 Spain: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
- 9.1.1.6.3.2 Spain: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
- 9.1.1.6.4 Spain: Europe Cerebrospinal Fluid Management Market, by End User
- 9.1.1.7 Rest of Europe
- 9.1.1.7.1 Overview
- 9.1.1.7.2 Rest of Europe: Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
- 9.1.1.7.3 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by Product
- 9.1.1.7.3.1 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by CSF Shunts
- 9.1.1.7.3.2 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
- 9.1.1.7.4 Rest of Europe: Europe Cerebrospinal Fluid Management Market, by End User
10. Europe Cerebrospinal Fluid Management Market -Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies in The Europe Cerebrospinal Fluid Management Market, 2020-2023
- 10.3 Inorganic Growth Strategies
- 10.4 Organic Growth Strategies
11. Company Profiles
- 11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Integra LifeSciences Holdings Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 B. Braun SE
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Argi Group Health Services Ltd Sti
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 Sophysa SA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Delta Surgical Ltd
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 Moller Medical GmbH
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Natus Medical Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Spiegelberg GmbH & Co KG
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
12. Appendix
- 12.1 About Us
- 12.2 Glossary of Terms
